Phenomenology and Outcomes of In-Patients With Parkinson's Disease During the Coronavirus Disease 2019 Pandemic.
作者信息
Kobylecki Christopher, Jones Theodora, Lim Cheng Khuang, Miller Carol, Thomson Alexander M
机构信息
Department of Neurology, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, United Kingdom.
Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom.
出版信息
Mov Disord. 2020 Aug;35(8):1295-1296. doi: 10.1002/mds.28205. Epub 2020 Jul 31.
Abstract
摘要
相似文献
1
Phenomenology and Outcomes of In-Patients With Parkinson's Disease During the Coronavirus Disease 2019 Pandemic.2019年冠状病毒病大流行期间帕金森病住院患者的现象学与结局
Mov Disord. 2020 Aug;35(8):1295-1296. doi: 10.1002/mds.28205. Epub 2020 Jul 31.
2
Impact of Coronavirus Disease 2019 Pandemic on Cognition in Parkinson's Disease.2019年冠状病毒病大流行对帕金森病认知功能的影响
Mov Disord. 2020 Oct;35(10):1717-1718. doi: 10.1002/mds.28254. Epub 2020 Sep 8.
3
ICU outcomes in Covid-19 patients with obesity.肥胖的新冠肺炎患者在重症监护病房的治疗结果
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620971146. doi: 10.1177/1753466620971146.
4
Resuscitation in COVID-19 patients: What do we know and what should we do?COVID-19患者的复苏：我们知道什么以及我们应该做什么？
Cardiol J. 2020;27(5):656-657. doi: 10.5603/CJ.2020.0161.
5
What can Parkinson's disease teach us about COVID-19?帕金森病能让我们对新冠病毒有哪些了解？
Neurol Neurochir Pol. 2020;54(2):204-206. doi: 10.5603/PJNNS.a2020.0039. Epub 2020 Apr 23.
6
Novel viruses, old data, and basic principles: how to save lives and avoid harm amid the unknown.新型病毒、旧有数据与基本原则：在未知中如何拯救生命并避免伤害。
Lancet Respir Med. 2020 Jul;8(7):661-663. doi: 10.1016/S2213-2600(20)30236-8. Epub 2020 May 21.
7
Clinical Characteristics of Patients Who Died of Coronavirus Disease 2019 in China.中国新冠肺炎死亡患者的临床特征。
JAMA Netw Open. 2020 Apr 1;3(4):e205619. doi: 10.1001/jamanetworkopen.2020.5619.
8
Outcome of Parkinson's Disease Patients Affected by COVID-19.受新冠病毒感染的帕金森病患者的结局
Mov Disord. 2020 Jun;35(6):905-908. doi: 10.1002/mds.28104. Epub 2020 May 28.
9
Clinical Course and Mortality of Stroke Patients With Coronavirus Disease 2019 in Wuhan, China.中国武汉 COVID-19 卒中患者的临床病程和死亡率。
Stroke. 2020 Sep;51(9):2674-2682. doi: 10.1161/STROKEAHA.120.030642. Epub 2020 Jul 31.
10
We urgently need guidelines for managing COVID-19 in children with comorbidities.我们迫切需要针对患有合并症的儿童管理新冠病毒病的指南。
Acta Paediatr. 2020 Jul;109(7):1497-1498. doi: 10.1111/apa.15304. Epub 2020 May 6.
引用本文的文献
1
Movement Disorders and SARS-CoV-2.运动障碍与严重急性呼吸综合征冠状病毒2
Mov Disord Clin Pract. 2022 Dec 7;10(Suppl 2):S9-S17. doi: 10.1002/mdc3.13615. eCollection 2023 Aug.
2
Clinical features and outcomes of hospitalised patients with COVID-19 and Parkinsonian disorders: A multicentre UK-based study.COVID-19 住院患者与帕金森病患者的临床特征和转归：一项基于英国多中心的研究。
PLoS One. 2023 Jul 31;18(7):e0285349. doi: 10.1371/journal.pone.0285349. eCollection 2023.
3
The Beneficial Role of Photobiomodulation in Neurodegenerative Diseases.光生物调节在神经退行性疾病中的有益作用。
Biomedicines. 2023 Jun 26;11(7):1828. doi: 10.3390/biomedicines11071828.
4
Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital.帕金森病患者中 COVID-19 的患病率和结局：急症环境和医院。
Int Rev Neurobiol. 2022;165:35-62. doi: 10.1016/bs.irn.2022.03.001. Epub 2022 Apr 20.
5
Viruses, parkinsonism and Parkinson's disease: the past, present and future.病毒、帕金森病与帕金森病：过去、现在与未来。
J Neural Transm (Vienna). 2022 Sep;129(9):1119-1132. doi: 10.1007/s00702-022-02536-y. Epub 2022 Aug 29.
6
COVID-19 outcomes in hospitalized Parkinson's disease patients in two pandemic waves in 2020: a nationwide cross-sectional study from Germany.2020年两波疫情期间德国住院帕金森病患者的新冠病毒病结局：一项全国性横断面研究
Neurol Res Pract. 2022 Jul 11;4(1):27. doi: 10.1186/s42466-022-00192-x.
7
The Influence of Coronavirus Disease-2019 (COVID-19) On Parkinson's Disease: An Updated Systematic Review.新型冠状病毒肺炎（COVID-19）对帕金森病影响的系统评价更新。
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211039709. doi: 10.1177/21501327211039709.
8
[Not Available].[无可用内容]。
Neurologia (Engl Ed). 2021 Aug 2. doi: 10.1016/j.nrl.2021.07.002.
9
Covid-19 and Parkinson's disease: an overview.Covid-19 与帕金森病：概述。
J Neurol. 2021 Dec;268(12):4415-4421. doi: 10.1007/s00415-021-10721-4. Epub 2021 Jul 27.
10
The impact of Parkinson's disease on manifestations and outcomes of Covid-19 patients: A systematic review and meta-analysis.帕金森病对新冠病毒感染者临床表现和结局的影响：系统评价和荟萃分析。
Rev Med Virol. 2022 Mar;32(2):e2278. doi: 10.1002/rmv.2278. Epub 2021 Jul 14.
本文引用的文献
1
COVID-19 in Parkinson's Disease Patients Living in Lombardy, Italy.意大利伦巴第地区帕金森病患者的 COVID-19 状况。
Mov Disord. 2020 Jul;35(7):1089-1093. doi: 10.1002/mds.28176. Epub 2020 Jun 26.
2
Effects of COVID-19 on Parkinson's Disease Clinical Features: A Community-Based Case-Control Study.新冠疫情对帕金森病临床特征的影响：一项基于社区的病例对照研究。
Mov Disord. 2020 Aug;35(8):1287-1292. doi: 10.1002/mds.28170. Epub 2020 Jun 11.
3
Outcome of Parkinson's Disease Patients Affected by COVID-19.受新冠病毒感染的帕金森病患者的结局
Mov Disord. 2020 Jun;35(6):905-908. doi: 10.1002/mds.28104. Epub 2020 May 28.
4
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
5
Origin and Evolution of the 2019 Novel Coronavirus.2019新型冠状病毒的起源与进化
Clin Infect Dis. 2020 Jul 28;71(15):882-883. doi: 10.1093/cid/ciaa112.
Zotero 插件